文献速递鼻科

术中使用额窦莫米松洗脱支架降低慢性鼻窦炎伴鼻息肉患者的白介素5和白介素13

Use of intraoperative frontal sinus mometasone-eluting stents decreased interleukin 5 and interleukin 13 in patients with chronic rhinosinusitis with nasal polyps.
PubMed 文献 · Int Forum Allergy Rhinol · 2022-05-19

研究纳入52例慢性鼻窦炎伴鼻息肉患者,33例术中接受额窦莫米松洗脱支架、19例未接受,比较术前及术后6至12个月中鼻道黏液2型炎症介质与疾病严重程度。支架组术后白介素5和白介素13下降,非支架组未观察到此变化;但症状和影像学严重程度无显著差异。

要点

  • 支架组术后白介素5(p<0.05)和白介素13(p<0.001)下降,非支架组未观察到。
  • 术后非支架组白介素4和白介素13高于支架组(两者p<0.05)。
  • 上述变化未对应症状或影像学疾病严重程度的显著差异。

核心结论

  • 接受额窦莫米松洗脱支架的患者术前中鼻道白介素13和嗜酸性阳离子蛋白较高,但术后中位8个月时白介素4和白介素13低于未接受支架者。
  • 这些变化未对应症状或影像学疾病严重程度的显著差异。

研究设计与样本

  • 研究在52例慢性鼻窦炎伴鼻息肉患者中于内镜手术前及术后6至12个月收集中鼻道黏液和经过验证的疾病严重程度指标。
  • 33例术中接受额窦莫米松洗脱支架,与19例未接受者进行比较,比较手术所见、2型炎症介质浓度、术中变量和疾病严重程度指标。

主要发现

  • 支架组术前中鼻道白介素13和嗜酸性阳离子蛋白高于非支架组(p<0.05),但术前临床疾病严重程度、手术范围及术后药物治疗相似。
  • 术中嗜酸性黏蛋白在支架组更常见(58% vs 11%,p=0.001)。
  • 支架组术后白介素5(p<0.05)和白介素13(p<0.001)下降,非支架组未观察到此变化。
  • 术后非支架组白介素4和白介素13高于支架组(两者p<0.05)。

关键数值与推荐

  • 支架组33例,非支架组19例,共52例慢性鼻窦炎伴鼻息肉患者。
  • 支架组术前中鼻道白介素13和嗜酸性阳离子蛋白较高(p<0.05)。
  • 术中嗜酸性黏蛋白支架组58% vs 非支架组11%(p=0.001)。
  • 支架组术后白介素5下降(p<0.05)、白介素13下降(p<0.001)。
  • 术后非支架组白介素4和白介素13高于支架组(两者p<0.05)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Mometasone-eluting stents (MES) have demonstrated improvement in short-term endoscopic outcomes and reduce short- to medium-term rescue interventions. Their effect on the local inflammatory environment, longer-term patient-reported outcomes, and radiographic severity have not been studied. METHODS: Middle meatal mucus and validated measures of disease severity were collected before and 6 to 12 months after endoscopic surgery in 52 patients with chronic rhinosinusitis with nasal polyps (CRSwNPs). Operative findings, type 2 mediator concentrations, intraoperative variables, and disease severity measures were compared between those who did and those who did not receive intraoperative frontal MES. RESULTS: A total of 52 patients with CRSwNPs were studied; 33 received frontal MES and were compared with 19 who did not. Pre-endoscopic sinus surgery (ESS) middle meatus (MM) interleukin (IL) 13 and eosinophil cationic protein (ECP) were higher in the stented group (p < 0.05), but pre-ESS clinical measures of disease severity were similar as were surgical extent and post-ESS medical management. Intraoperative eosinophilic mucin was more frequent in the stented group (58% vs 11%, p = 0.001). IL-5 (p < 0.05) and IL-13 (p < 0.001) decreased post-ESS in the stented group, but this was not observed in the nonstented group. Post-ESS IL-4 and IL-13 were higher in the nonstented vs stented group (p < 0.05 for both). CONCLUSION: Although patients who received intraoperative frontal MES had significantly higher pre-ESS MM IL-13 and ECP, patients who received frontal MES had lower concentrations of IL-4 and IL-13 than those who did not at a median of 8 months post-ESS. However, these changes did not correspond to significantly different measures of symptomatic or radiographic disease severity.

来源:Int Forum Allergy Rhinol,查看原文。版权归原作者所有。

引用

  1. Schneider AL, Racette SD, Kang AK, et al. Use of intraoperative frontal sinus mometasone-eluting stents decreased interleukin 5 and interleukin 13 in patients with chronic rhinosinusitis with nasal polyps. Int Forum Allergy Rhinol. 2022. PMID: 35362251. doi:10.1002/alr.23005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。